Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Charlevoix › NPI 1346260692
Hospital

Munson Healthcare Charlevoix Hospital

Munson Healthcare Charlevoix Hospital was paid $8.26M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 24% of everything it billed.

33Billing provider infoMUNSON HEALTHCARE CHARLEVOIX HOSPITAL
CHARLEVOIX, MI 49720
33aNPI1346260692assigned 07/20/2006
33bProvider typeCritical Access Hospital
28Total paid$8.26M
24GClaims213,366
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Michigan

Rank by total paid#9 of 31
Median peer was paid$6.03M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,744$812K
201929,322$861K
202025,638$994K
202130,010$1.23M
202236,067$1.48M
202338,781$1.58M
2024incomplete27,804$1.30M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 24% 32,104 28,671 $2.01M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 5,331 4,984 $1.25M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 6,933 6,628 $1.06M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 2,619 2,428 $940K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4.8% 3,361 3,020 $397K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.8% 10,022 3,164 $316K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 1,150 1,106 $247K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.9% 2,680 2,676 $158K
96361 Intravenous infusion, hydration; each additional hour 1.9% 3,566 2,990 $158K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.8% 2,560 2,496 $149K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 1,345 1,128 $141K
96375 Therapeutic injection; each additional sequential IV push 1.4% 2,745 2,344 $114K
126 more codes
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 865 $112K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 1,145 $106K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.3% 5,489 $105K
71045 Radiologic examination, chest; single view 1.1% 1,886 $93K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.0% 1,467 $84K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,384 $78K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,589 $77K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,846 $73K
G0378 Hospital observation service, per hour <1% 457 $57K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 509 $50K
97161 <1% 578 $36K
71046 Radiologic examination, chest; 2 views <1% 851 $34K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 600 $33K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 729 $27K
Q3014 Telehealth originating site facility fee <1% 1,321 $27K
70450 Computed tomography, head or brain; without contrast material <1% 329 $27K
80061 Lipid panel <1% 1,785 $23K
77067 Screening mammography, bilateral, including computer-aided detection <1% 348 $21K
80053 Comprehensive metabolic panel <1% 10,157 $19K
97162 <1% 392 $18K
84443 Thyroid stimulating hormone (TSH) <1% 3,760 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,516 $18K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 173 $17K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 13,518 $16K
86900 <1% 392 $13K
76830 Ultrasound, transvaginal <1% 126 $10K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 158 $9K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 971 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,734 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,724 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,258 $8K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 112 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,669 $5K
36415 Collection of venous blood by venipuncture <1% 10,044 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 68 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 30 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,431 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 108 $4K
87088 <1% 2,319 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 722 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 289 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 2,838 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 208 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 36 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 51 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 153 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 230 $2K
97035 <1% 320 $2K
82947 <1% 13 $2K
81001 <1% 6,866 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 197 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 30 $1K
83735 <1% 5,931 $898.02
73564 <1% 25 $679.49
86780 <1% 52 $532.78
85610 <1% 1,001 $527.24
86140 <1% 614 $519.07
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,396 $474.30
83690 <1% 2,847 $419.66
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 480 $414.30
87081 <1% 373 $399.91
73630 <1% 85 $383.05
87400 <1% 1,033 $364.41
85652 <1% 659 $324.94
86803 <1% 61 $272.52
81025 <1% 2,420 $265.78
73030 <1% 41 $246.98
84439 <1% 57 $244.07
87510 <1% 40 $237.82
87480 <1% 40 $237.82
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 542 $230.73
87660 <1% 40 $223.02
82728 <1% 56 $218.28
87420 <1% 248 $205.89
87071 <1% 146 $202.26
87186 <1% 104 $184.62
80306 <1% 1,418 $176.87
82607 <1% 42 $175.10
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 12 $169.27
73610 <1% 45 $153.45
87077 <1% 102 $131.82
87070 <1% 110 $127.06
87340 <1% 28 $118.97
82248 <1% 1,552 $110.07
83880 <1% 56 $88.17
86762 <1% 14 $80.54
84484 <1% 1,391 $63.21
83605 <1% 1,182 $56.16
85730 <1% 343 $55.65
86850 <1% 231 $46.19
84702 <1% 15 $33.33
85379 <1% 185 $31.46
82043 <1% 12 $27.90
84703 <1% 274 $27.34
80076 <1% 54 $22.25
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 6,217 $20.94
82948 <1% 335 $11.97
82746 <1% 12 $10.85
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,143 $5.68
82150 <1% 56 $4.07
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,345 $0.05
80143 0% 209 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 234 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 171 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 105 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 15 $0.00
94642 0% 14 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 12 $0.00
J2704 Injection, propofol, 10 mg 0% 1,979 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 427 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 489 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 1,739 $0.00
A9900 Miscellaneous dme supply, accessory, and/or service component of another hcpcs code 0% 27 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 1,537 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 42 $0.00
J3490 Unclassified drugs 0% 272 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 91 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 1,557 $0.00
A9270 Non-covered item or service 0% 290 $0.00
J1094 Injection, dexamethasone acetate, 1 mg 0% 167 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 90 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 126 $0.00
96376 0% 44 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 13 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 31 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKORTH-WHITE, KIRSTEN (PRESIDENT/CEO EAST REGION)
Parent organizationMUNSON HEALTHCARE
Same official

Other billing entities under KORTH-WHITE, KIRSTEN

Full network →
ProviderLocationPaid
Munson Healthcare GraylingGrayling, MI$13.93M
Munson Healthcare Manistee HospitalManistee, MI$9.52M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.